vs
Side-by-side financial comparison of LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) and TSS, Inc. (TSSI). Click either name above to swap in a different company.
TSS, Inc. is the larger business by last-quarter revenue ($60.9M vs $31.1M, roughly 2.0× LIFECORE BIOMEDICAL, INC. \DE\). TSS, Inc. runs the higher net margin — 20.0% vs -32.1%, a 52.1% gap on every dollar of revenue. On growth, TSS, Inc. posted the faster year-over-year revenue change (21.8% vs -4.5%). TSS, Inc. produced more free cash flow last quarter ($15.8M vs $25.0K). Over the past eight quarters, TSS, Inc.'s revenue compounded faster (95.8% CAGR vs -0.1%).
LIFECORE BIOMEDICAL, INC. is a biomedical firm focused on developing and manufacturing high-quality hyaluronic acid-based biomaterials. It operates three core segments: medical application products, pharmaceutical solutions, and personal care ingredients, with main markets spanning North America, Europe and the Asia-Pacific, supplying to leading medical device, pharmaceutical and cosmetic brand partners.
LFCR vs TSSI — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $31.1M | $60.9M |
| Net Profit | $-10.0M | $12.2M |
| Gross Margin | 25.0% | 17.6% |
| Operating Margin | -9.9% | 1.5% |
| Net Margin | -32.1% | 20.0% |
| Revenue YoY | -4.5% | 21.8% |
| Net Profit YoY | -52.0% | 535.7% |
| EPS (diluted) | $-0.29 | $0.44 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $60.9M | ||
| Q3 25 | $31.1M | $41.9M | ||
| Q2 25 | — | $44.0M | ||
| Q1 25 | $35.2M | $99.0M | ||
| Q4 24 | $32.6M | $50.0M | ||
| Q3 24 | $24.7M | $70.1M | ||
| Q2 24 | — | $12.2M | ||
| Q1 24 | $35.7M | $15.9M |
| Q4 25 | — | $12.2M | ||
| Q3 25 | $-10.0M | $-1.5M | ||
| Q2 25 | — | $1.5M | ||
| Q1 25 | $-14.8M | $3.0M | ||
| Q4 24 | $-6.6M | $1.9M | ||
| Q3 24 | $-16.2M | $2.6M | ||
| Q2 24 | — | $1.4M | ||
| Q1 24 | $15.6M | $15.0K |
| Q4 25 | — | 17.6% | ||
| Q3 25 | 25.0% | 11.1% | ||
| Q2 25 | — | 17.8% | ||
| Q1 25 | 28.0% | 9.3% | ||
| Q4 24 | 34.0% | 14.4% | ||
| Q3 24 | 21.8% | 11.3% | ||
| Q2 24 | — | 37.3% | ||
| Q1 24 | 33.3% | 17.1% |
| Q4 25 | — | 1.5% | ||
| Q3 25 | -9.9% | -2.2% | ||
| Q2 25 | — | 5.1% | ||
| Q1 25 | -25.7% | 4.2% | ||
| Q4 24 | -6.0% | 0.0% | ||
| Q3 24 | -46.9% | 5.4% | ||
| Q2 24 | — | 14.0% | ||
| Q1 24 | -2.5% | 1.6% |
| Q4 25 | — | 20.0% | ||
| Q3 25 | -32.1% | -3.6% | ||
| Q2 25 | — | 3.4% | ||
| Q1 25 | -42.0% | 3.0% | ||
| Q4 24 | -20.2% | 3.8% | ||
| Q3 24 | -65.7% | 3.8% | ||
| Q2 24 | — | 11.5% | ||
| Q1 24 | 43.8% | 0.1% |
| Q4 25 | — | $0.44 | ||
| Q3 25 | $-0.29 | $-0.06 | ||
| Q2 25 | — | $0.06 | ||
| Q1 25 | $-0.47 | $0.12 | ||
| Q4 24 | $-0.25 | $0.08 | ||
| Q3 24 | $-0.53 | $0.10 | ||
| Q2 24 | — | $0.06 | ||
| Q1 24 | $0.42 | $0.00 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $18.9M | $85.5M |
| Total DebtLower is stronger | $136.0M | — |
| Stockholders' EquityBook value | $-10.5M | $76.6M |
| Total Assets | $235.2M | $184.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $85.5M | ||
| Q3 25 | $18.9M | $70.7M | ||
| Q2 25 | — | — | ||
| Q1 25 | $5.4M | — | ||
| Q4 24 | $9.5M | $23.2M | ||
| Q3 24 | — | $46.4M | ||
| Q2 24 | — | $8.3M | ||
| Q1 24 | — | $14.4M |
| Q4 25 | — | — | ||
| Q3 25 | $136.0M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $124.9M | — | ||
| Q4 24 | $111.3M | — | ||
| Q3 24 | $106.3M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $97.1M | — |
| Q4 25 | — | $76.6M | ||
| Q3 25 | $-10.5M | $63.4M | ||
| Q2 25 | — | $9.5M | ||
| Q1 25 | $2.2M | $9.4M | ||
| Q4 24 | $15.4M | $7.1M | ||
| Q3 24 | $-3.9M | $7.7M | ||
| Q2 24 | — | $5.2M | ||
| Q1 24 | $17.7M | $3.7M |
| Q4 25 | — | $184.9M | ||
| Q3 25 | $235.2M | $165.4M | ||
| Q2 25 | — | $139.5M | ||
| Q1 25 | $237.7M | $113.5M | ||
| Q4 24 | $255.4M | $96.6M | ||
| Q3 24 | $246.8M | $67.3M | ||
| Q2 24 | — | $28.9M | ||
| Q1 24 | $246.2M | $26.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 56.05× | — | ||
| Q4 24 | 7.20× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 5.49× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.8M | $16.3M |
| Free Cash FlowOCF − Capex | $25.0K | $15.8M |
| FCF MarginFCF / Revenue | 0.1% | 25.9% |
| Capex IntensityCapex / Revenue | 5.6% | 0.9% |
| Cash ConversionOCF / Net Profit | — | 1.34× |
| TTM Free Cash FlowTrailing 4 quarters | $-16.8M | $2.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $16.3M | ||
| Q3 25 | $1.8M | $-18.4M | ||
| Q2 25 | — | $16.3M | ||
| Q1 25 | $1.2M | $20.6M | ||
| Q4 24 | $-6.1M | $-21.6M | ||
| Q3 24 | $-613.0K | $38.6M | ||
| Q2 24 | — | $-4.3M | ||
| Q1 24 | $-1.4M | $2.6M |
| Q4 25 | — | $15.8M | ||
| Q3 25 | $25.0K | $-24.9M | ||
| Q2 25 | — | $5.4M | ||
| Q1 25 | $-4.3M | $5.8M | ||
| Q4 24 | $-8.6M | $-28.4M | ||
| Q3 24 | $-4.0M | $38.6M | ||
| Q2 24 | — | $-6.0M | ||
| Q1 24 | $-7.8M | $2.6M |
| Q4 25 | — | 25.9% | ||
| Q3 25 | 0.1% | -59.3% | ||
| Q2 25 | — | 12.3% | ||
| Q1 25 | -12.1% | 5.8% | ||
| Q4 24 | -26.3% | -56.7% | ||
| Q3 24 | -16.3% | 55.1% | ||
| Q2 24 | — | -49.4% | ||
| Q1 24 | -21.8% | 16.4% |
| Q4 25 | — | 0.9% | ||
| Q3 25 | 5.6% | 15.3% | ||
| Q2 25 | — | 24.8% | ||
| Q1 25 | 15.5% | 15.0% | ||
| Q4 24 | 7.5% | 13.4% | ||
| Q3 24 | 13.9% | 0.1% | ||
| Q2 24 | — | 13.8% | ||
| Q1 24 | 17.8% | 0.2% |
| Q4 25 | — | 1.34× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 11.02× | ||
| Q1 25 | — | 6.93× | ||
| Q4 24 | — | -11.32× | ||
| Q3 24 | — | 14.60× | ||
| Q2 24 | — | -3.09× | ||
| Q1 24 | -0.09× | 176.40× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LFCR
| Transferred At Point In Time | $26.6M | 85% |
| Transferred Over Time | $4.5M | 15% |
TSSI
| Procurement Revenues Segment | $43.2M | 71% |
| System Integration Services Segment | $14.2M | 23% |
| Facilities Segment | $3.5M | 6% |
